About us

Adelis is an analytical instrumentation company with a long-standing reputation since 1999. Our objective is to provide high-precision and high sensitivity separative analysis technologies which are used in R&D, pharmaceutical companies quality control laboratories, research institutes and universities in Europe, North America and Asia.

Excellence through innovation and close collaborations

Since the beginning, Adelis has been driven by the ambition for excellence through innovation and close collaborations with major laboratories and universities.
Today, Adelis offers to the market a complete platform to analyse DNA and more particularly circulating cell-free DNA in blood samples. We aim to improve the quality of care in precision medecine with personalised diagnostics.

Management team

Philippe Pourquier

Chairman & CEO

Philippe, Chairman and CEO of Adelis since 2018, is an accomplished entrepreneur as well as an inspiring and strategic leader. He brings to Adelis his recognised experience in the development and business of biotechnology, diagnostic and molecular biology tests.
Philippe obtained his Paris Tech Agro Engineer diploma in 1985. After various experiences in public research, he became Technical Director of a family business specialising in veterinary diagnostics. In 2004, he created IDVET, now Innovative Diagnostic of which he is the CEO. He has been involved in the creation of various company and recently acquired Biodena Care a company specialised oncology biomarker.

Jean Charles Garcia

Chief Operating Officer

Jean Charles is the founder and COO of Adelis. He brings more than 30 years of experience in developing products and bringing new technologies to market in a wide variety of industries, particularly complex and innovative analytical equipment and methods. He obtained his engineering degree in 1985 (INSA Toulouse-France) then his PhD in physics in 1988 (CNRS, Sophia Antipolis). For more than 10 years he created or has been involved in the creation of six companies specialised in industrial instrumentation, telecommunications and software.

Frédéric Ginot

Chief Technology Officer

Frédéric is the CTO of Adelis. He brings his dual expertise in instrument engineering and biology. He is graduated from École Polytechnique (Paris – France, 1985) and obtained a PhD in Molecular Biology (University Paris VII, 1989). He has 29 years of experience in the biology and biotechnology sector. He has managed several development teams on industrial projects, always at the interface between engineering and biosciences, especially in medical devices (Hemodia), in vitro diagnostics (BioMérieux, CEA-LETI) and molecular biology (Genethon, Bertin Technologies).

Contact us for further information

Get in touch with us
Main office:

478 rue de la Découverte
31670 LABEGE – France
Tel. +33 (0)5 31 61 50 90

  • Analytical platforms

FOLLOW US

Copyright © 2024 Adelis SAS